The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients-Reference-Cited by-同舟云学术

The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients

Published:2020-07-20 Issue:7 Volume:15 Page:e0235638
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gostelie Romee^ORCID,Stegeman Inge,Berkers Gitte,Bittermann Joost,Ligtenberg-van der Drift Ivonne,Kipshagen Peter-Jan van,de Winter - de Groot Karin,Speleman Lucienne

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Birth prevalence and survival in cystic fibrosis: A national cohort study in the Netherlands;MG Slieker;Chest,2005

2. World Health Organization (2019), Patients and Public, Genes and Human diseases, Cystic Fibrosis. Available from: https://www.who.int/genomics/public/geneticdiseases/en/index2.html#CF

3. Cystic Fibrosis;JS Elborn;The Lancet,2016

4. Cystic fibrosis;BP O'Sullivan;The Lancet,2009

5. Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management;C Gysin;Pediatr Pulmonol,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional and radiological sinonasal outcomes of CFTR modulators for sinus disease in cystic fibrosis: A meta‐analysis;International Forum of Allergy & Rhinology;2024-08-30

2. Dual and triple modulator therapy for chronic rhinosinusitis in cystic fibrosis patients;Rhinology Journal;2024-03-01

3. Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis;Journal of Cystic Fibrosis;2024-03

4. Potential systemic effects of acquired CFTR dysfunction in COPD;Respiratory Medicine;2024-01

5. Radiological and clinical evaluation of triple combination modulating therapy effectiveness in adult patients with cystic fibrosis;Meta-Radiology;2023-11